Strategies for Successful Life Sciences Deal Making
5 April, 2023Life Sciences deal making is a crowded but attractive field. Research firm Bain and Company reports that there are some 3425 biotech businesses in the US at the start of 2023
Life Sciences deal making is a crowded but attractive field. Research firm Bain and Company reports that there are some 3425 biotech businesses in the US at the start of 2023
In the fast-paced and highly competitive world of life sciences, intellectual property management is a critical component of deal making.
Strict security policies not only protect customers, it instills trust in your company’s brand in the marketplace.
The Biotech sector is experiencing a tough slog. Share values are down and venture capital funds are growing scarce, even for formerly white-hot categories like Oncology drugs. Industry analysts are calling it a “Biotech Winter.”
Cybersecurity is essential for global dealmakers. Check out our webinar to learn the successes and challenges of doing deals remotely.
Cybersecurity is essential for pharmaceutical companies. These are their biggest threats — and how to mitigate them for product development and innovation.
Gone are the days of swinging by a coworker’s desk for feedback. These are the main benefits of using an online document editor — and everything you need to know to do it right.
Redlining is an essential activity in any contract negotiations, discover what you need to know about redlining and write more agreements with fewer disagreements.
You’ve had the COVID vaccine and been boosted. You’ve been vaccinated against measles, mumps and rubella. You’ve likely had tetanus, chicken pox and a flu shot. But have you been vaccinated for cancer?
Every corporate team can increase efficiency by implementing secure online collaboration. Read on to discover the top five proven benefits of this new way of work.